A detailed history of Jackson Creek Investment Advisors LLC transactions in Castle Biosciences Inc stock. As of the latest transaction made, Jackson Creek Investment Advisors LLC holds 57,094 shares of CSTL stock, worth $1.07 Million. This represents 0.36% of its overall portfolio holdings.

Number of Shares
57,094
Holding current value
$1.07 Million
% of portfolio
0.36%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 05, 2025

BUY
$18.76 - $32.72 $1.07 Million - $1.87 Million
57,094 New
57,094 $1.14 Million

Others Institutions Holding CSTL

About CASTLE BIOSCIENCES INC


  • Ticker CSTL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 26,297,000
  • Market Cap $493M
  • Description
  • Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...
More about CSTL
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.